临床试验
放射性核素治疗
医学物理学
阿斯汀
医学
α粒子
阿尔法(金融)
放射性核素
核医学
核物理学
内科学
物理
外科
结构效度
量子力学
电压
患者满意度
作者
Per Albertsson,Tom Bäck,Karin Bergmark,Andreas Hallqvist,Mia Johansson,Emma Aneheim,Sture Lindegren,Chiara Timperanza,Knut T. Smerud,Stig Palm
标识
DOI:10.3389/fmed.2022.1076210
摘要
Astatine-211 ( 211 At) has physical properties that make it one of the top candidates for use as a radiation source for alpha particle-based radionuclide therapy, also referred to as targeted alpha therapy (TAT). Here, we summarize the main results of the completed clinical trials, further describe ongoing trials, and discuss future prospects.
科研通智能强力驱动
Strongly Powered by AbleSci AI